REREP2Y

Q-omics provides the consensus-scored REREP2Y profile across patient tissues and cancer cell-line models. REREP2Y expression is associated with patient survival in 2 of 34 cancer types, with the highest sampling consensus in STAD. Additionally, REREP2Y RNA expression shows 146 significant protein co-abundance associations, with the highest sampling consensus in UCEC. Together, these results highlight STAD, and UCEC as cancer lineages where REREP2Y shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Survival associations

This table summarizes REREP2Y survival associations across molecular data types. REREP2Y RNA expression shows survival associations in the most cancer types (2). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

REREP2Y data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	2	STAD (63)	view →

This table ranks reproducible REREP2Y RNA expression–survival associations across cancer types. High REREP2Y expression shows unfavorable associations in STAD and ESCA. The STAD Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .001). Together, the overview and detailed table identify STAD as the clearest survival context for REREP2Y RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Tertile	All	0.184	0.730	.001	63	view →
ESCA	DFS	Tertile	All	0.126	0.536	<.001	36	view →

Pink = unfavorable, green = favorable. all 2 lineages →

REREP2Y-STAD (OS)

Explore this curve interactively →